Lymphoma Cancer | Tumor

CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.

Yescarta for Relapsed/Refractory Large B-Cell Lymphoma May Represent a ‘Paradigm Shift’ in Second-Line Treatment

January 14th 2022

CAR-T cell therapy with Yescarta in patients with relapsed/refractory large B-cell lymphoma had improved responses to treatment and survival in the second-line setting, which may help save more lives than standard care, an expert said.

Prophylactic Monoclonal Antibodies Recommended to Protect Certain Patients With Cancer From COVID-19

January 11th 2022

The National Comprehensive Cancer Network now recommends prophylactic monoclonal antibodies for immunosuppressed individuals, such as certain patients with cancer.

Trial Launched to Assess Safety and Efficacy of Novel Drug in Rare Type of Head and Neck Cancer

January 10th 2022

A phase 2 trial was recently launched to examine the safety and efficacy of oral inhibitor VK-2019 in patients with advanced Epstein-Barr Virus-positive nasopharyngeal carcinoma, a rare type of head and neck cancer, and lymphoma.

Cancer Drug Approvals from 2021 That Patients May Have Missed

December 28th 2021

2021 was full of research advancements and FDA drug approvals that continue to improve cancer care for patients with a variety of malignancies.

Third Full Dose of COVID-19 Vaccine Increases Antibody Response in Patients with Blood Cancers

December 23rd 2021

New findings show that 43% of patients with certain blood cancers produced COVID-19 antibodies after receiving a third full dose of the mRNA vaccine.

FDA Approves Orencia for GVHD Prevention After Hematopoietic Stem Cell Transplant

December 15th 2021

The Food and Drug Administration approved Orencia, which is commonly used to treat conditions like rheumatoid arthritis, to prevent acute graft-versus-host-disease in adults and children who underwent a hematopoietic stem cell transplant from an unrelated donor.

New Treatment Regimen May Reduce GvHD, the ‘Most Common and Feared Complication’ of Stem Cell Transplantation

December 14th 2021

The addition of a drug commonly used to treat arthritis may reduce the risk of graft-versus-host-disease in patients who underwent haploidentical allogeneic stem cell transplant.

Novel Drug Plus Rituxan May Serve as ‘New Treatment Option’ for Relapsed/Refractory Lymphoma Subset

December 13th 2021

The use of a novel drug combination yielded positive outcomes in patients with B-cell lymphomas for whom CAR-T cell therapy or stem cell transplant isn’t an option.

Cancer Clinical Trial Enrollment Is Low in the US, and Patient Depression and Anxiety May Play a Role

December 12th 2021

Researchers found that depression and anxiety may skew patient perceptions of participating in blood cancer clinical trials, thus contributing to low enrollment throughout the United States.

CAR-T Cell Therapy Bests Standard of Care in Health-Related Quality of Life for Patients With Lymphoma

December 11th 2021

Patients with large B-cell lymphoma tended to have better quality of life that continued to improve over time after receiving Breyzani compared to those given standard of care.

FDA Approves Rituxan-Chemotherapy Combo for Children with a Variety of Blood Cancers

December 3rd 2021

The FDA approval of Rituxan plus chemotherapy is indicated for the treatment of children aged six months to 18 years who have various forms of lymphoma or a form of leukemia.

COVID-19 May Increase Mortality Risk in Older Patients With B-Cell Malignancies, Among Others

November 29th 2021

Patients aged 60 years and older with B-cell malignancies and those who were current or former smokers may have an increased risk for death after a COVID-19 infection, also outcomes may be better for those diagnosed after June 2020.

Dick Vitale Makes Tearful Return to Basketball After Leaving for Cancer Treatment

November 26th 2021

From Dick Vitale’s return to sportscasting after a brief pause for cancer treatment to a cancer survivor walking 3,000 miles cross-country, here’s what’s happening in the cancer landscape this week.

Assessing Both Sides of the Argument for In-Home Cancer Infusions

November 18th 2021

Although the interest of at-home care including the administration of cancer infusions has grown since the start of the COVID-19 pandemic, hesitation looms over its convenience, cost and safety.

Study Initiated for Bispecific Antibody in Patients With T-cell Lymphoma

November 10th 2021

A phase 1 trial of ONO-4685 was initiated for the evaluation of the antibody in patients with relapsed or refractory t-cell lymphoma.

FDA’s New Recommendations on Risk of Breast Implants an ‘Enormous Step Forward’ For Patients With Breast Cancer

November 4th 2021

The FDA’s recommendations are aimed at helping individuals and patients with breast cancer make better informed decisions about the decision to receive breast implants, according to experts.

Patients With Lymphoma May Be At Risk for Chemo Brain

October 27th 2021

Memory, attention and the ability to multitask may be affected in patients with lymphoma during and after chemotherapy treatment, which can impact one’s capability to complete daily tasks.

New Treatments and Tips for Dealing With Blood Cancer

October 26th 2021

New research in blood cancer includes new treatment options for acute myeloid leukemia and a novel therapy using BK virus-specific T cells to treat BK virus-associated hemorrhagic cystitis.

What Does It Mean to Be a Cancer Survivor?

October 25th 2021

“When survival became my identity, things began to shift in my life forever,” writes a blood cancer survivor.

The Power of the Immune System: New Treatment for Painful Blood Cancer Side Effect

October 21st 2021

A new T-cell therapy can be highly effective in treating BKV-associated hemorrhagic cystitis while minimizing side effects.

What Patients With Blood Cancers Need to Know About COVID-19, Booster Shots and More

October 21st 2021

An expert from the Leukemia & Lymphoma Society breaks down the effectiveness of the COVID-19 vaccine in patients with blood cancers on this episode of the “Cancer Horizons” podcast.

Dick Vitale Receives Second Cancer Diagnosis in Recent Months

October 19th 2021

The ESPN sportscaster Dick Vitale was diagnosed with lymphoma, after receiving a melanoma diagnosis earlier this year.

The Future of Cancer Looks Bright With Engineered Cells

October 19th 2021

Engineered cell technology is an example of ingenuity that brings together cutting-edge laboratory science and clinical trials to address aggressive cancers.

Third COVID-19 Vaccine Dose in Blood Cancers May Boost Antibody Production

October 13th 2021

Patients with blood cancers may respond differently to doses of the COVID-19 vaccines based on the treatment they’re receiving, for example.

A New Line of Defense in Blood Cancer: Natural Killer Cell Therapy

October 11th 2021

Natural killer cell therapy is making strides in blood cancer research, but there’s still much more to learn.

It Takes a Village: Cancer Caregivers Need to Care for Themselves, Too

October 7th 2021

Caregivers of patients with cancer may face financial toxicity and stress — with little time to take care of themselves.

Mark Hoppus Announces He Is Cancer-Free, Olympian Swims 10.4 Miles in Honor of Her Late Father and More

October 1st 2021

From Blink-182 bandmember Mark Hoppus’s cancer update to Olympian Elizabeth Beisel’s swim for cancer, here’s what’s happening in the cancer landscape this week.

FDA Approval of Jakafi for Chronic GVHD Provides Another Option, But ‘More Work Needs to Be Done’

September 29th 2021

While the recent FDA approval of Jakafi offers another effective option for patients with chronic GVHD, one expert urges that more work needs to be done to prevent and/or reverse the condition.

Outcome Disparities Persist in Young Patients With Hodgkin Lymphoma

September 28th 2021

Certain races/ethnicities and ages may have worse outcomes in Hodgkin lymphoma regardless of variation in upfront chemotherapy.

New Book Written By Former Pediatric Oncologist Emphasizes Patients With Cancer ‘Are Not Alone’

September 22nd 2021

The tome also reflects on his own diagnosis of cancer and how it influenced his practice.